[Effects of prone position, inhaled nitric oxide and surfactant in children with hypoxemic pulmonary disease]

An Pediatr (Barc). 2003 Feb;58(2):106-14. doi: 10.1016/s1695-4033(03)78013-8.
[Article in Spanish]

Abstract

Objective: To analyze the therapeutic response to prone position, inhaled nitric oxide (NO) and surfactant in children with hypoxemic pulmonary disease.

Patients and methods: We studied the effect of prone position, NO, and surfactant in critically ill children with acute hypoxemic pulmonary disease unresponsive to conventional therapy. We analyzed PaO2, SatO2, the PaO2/FiO2 ratio, oxygenation index and PaCO2 before and after each treatment, as well as the subsequent clinical course. An increase of more than 20 % in the PaO2/FiO2 ratio was considered a positive response.

Results: Ninety treatments were administered in 56 patients: 55 patients were treated with NO, 18 with prone position and 17 with surfactant. All three treatments substantially improved oxygenation. The mean increase in the PaO2/FiO2 ratio was 35 % with nitric oxide, 33 % with prone position and 50 % with surfactant. The mean decrease in oxygenation index was 22 % with nitric oxide, 24 % with prone position and 17 % with surfactant. Seventy-one percent of patients treated with NO, 61 % of patients treated with prone position, and 64 % of patients who received surfactant were responders. The three treatments produced a slight decrease in PaCO2 (2.5 mmHg with nitric oxide, 4.7 mmHg with prone position and 5.1 mmHg with surfactant).

Conclusions: Inhaled NO, prone position and surfactant improve oxygenation in some children with hypoxic pulmonary disease.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Hypoxia / therapy*
  • Infant
  • Infant, Newborn
  • Male
  • Nitric Oxide / therapeutic use*
  • Posture*
  • Pulmonary Surfactants / administration & dosage*

Substances

  • Pulmonary Surfactants
  • Nitric Oxide